The human trial of COVID-19 vaccine candidate developed by the University of Oxford and backed by AstraZeneca Plc has shown a positive result. The researchers found their experimental COVID-19 vaccine produced a dual immune response in people aged 18 to 55. Oxford’s vaccine is designed to reduce disease and transmission. Director at the Jenner Institute of Oxford University, Dr Adrian Hill, explains the mechanism of this vaccine “this vaccine triggers both arms of the immune system”.
As per the British Medical Journal Lancet:
The vaccine was officially known as AZD1222, prompted a protective immune response in hundreds of people who got the shot and did not prompt any serious side effects. According to trial results published in The Lancet medical journal, the Covid-19 vaccine prompted no serious side effects and elicited antibody and T-cell immune responses with the strongest response seen in people who received two doses.
About AZD1222 vaccine:
World Water Day is observed globally on the March 22 and the day raise awareness…
Did you know there is a special island in the world where giant tortoises roam…
Did you know that beneath the ocean floor lies one of the most valuable energy…
Chapchar Kut which is the major spring festival of Mizoram and it was celebrated with…
Did you know that in many countries, rivers are not just water sources but the…
The New Income Tax Rules 2026 are notified and which will come into effect from…